Lee R, Piatt R, Dhenge A, Lozano M, Palma-Barqueros V, Rivera J
Sci Transl Med. 2019; 11(522).
PMID: 31826978
PMC: 10824274.
DOI: 10.1126/scitranslmed.aay0203.
Saab S, Brown Jr R
Dig Dis Sci. 2019; 64(10):2757-2768.
PMID: 31011942
DOI: 10.1007/s10620-019-05615-5.
Faiz S, Jimenez C, Fellman B, Huk T, Jazbeh S, Haque S
J Bronchology Interv Pulmonol. 2019; 26(4):280-286.
PMID: 30973520
PMC: 6768748.
DOI: 10.1097/LBR.0000000000000590.
Malouf R, Ashraf A, Hadjinicolaou A, Doree C, Hopewell S, Estcourt L
Cochrane Database Syst Rev. 2018; 5:CD012342.
PMID: 29758592
PMC: 5985156.
DOI: 10.1002/14651858.CD012342.pub2.
Fu J, Tennison J, Rutzen-Lopez I, Silver J, Morishita S, Dibaj S
Support Care Cancer. 2018; 26(9):3135-3141.
PMID: 29594490
DOI: 10.1007/s00520-018-4160-y.
Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders.
Ashraf A, Hadjinicolaou A, Doree C, Hopewell S, Trivella M, Estcourt L
Cochrane Database Syst Rev. 2016; 2016(9).
PMID: 27660553
PMC: 5027963.
DOI: 10.1002/14651858.CD012342.
A Novel Peptide Thrombopoietin Mimetic Designing and Optimization Using Computational Approach.
Singh V, Kumar N, Kalsan M, Saini A, Chandra R
Front Bioeng Biotechnol. 2016; 4:69.
PMID: 27630985
PMC: 5006622.
DOI: 10.3389/fbioe.2016.00069.
Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.
Estcourt L, Stanworth S, Doree C, Hopewell S, Trivella M, Murphy M
Cochrane Database Syst Rev. 2015; (11):CD010983.
PMID: 26576687
PMC: 4717525.
DOI: 10.1002/14651858.CD010983.pub2.
Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.
Estcourt L, Stanworth S, Doree C, Trivella M, Hopewell S, Murphy M
Cochrane Database Syst Rev. 2015; (3).
PMID: 25722651
PMC: 4338576.
DOI: 10.1002/14651858.CD010983.
Historical perspective and future directions in platelet research.
Coller B
J Thromb Haemost. 2011; 9 Suppl 1:374-95.
PMID: 21781274
PMC: 3163479.
DOI: 10.1111/j.1538-7836.2011.04356.x.
Thrombin generation in hemorrhage control and vascular occlusion.
Mann K
Circulation. 2011; 124(2):225-35.
PMID: 21747067
PMC: 3138077.
DOI: 10.1161/CIRCULATIONAHA.110.952648.
Pseudoplatelets: a retrospective study of their incidence and interference with platelet counting.
van der Meer W, MacKenzie M, Dinnissen J, De Keijzer M
J Clin Pathol. 2003; 56(10):772-4.
PMID: 14514782
PMC: 1770090.
DOI: 10.1136/jcp.56.10.772.
Component therapy.
Radhakrishnan K, Chakravarthi S, Pushkala S, Jayaraju J
Indian J Pediatr. 2003; 70(8):661-6.
PMID: 14510088
DOI: 10.1007/BF02724257.
Is automated platelet counting still a problem in thrombocytopenic blood?.
Oliveira R, Takadachi M, Nonoyama K, de Oliveira Barretto O
Sao Paulo Med J. 2003; 121(1):19-23.
PMID: 12751339
PMC: 11108610.
DOI: 10.1590/s1516-31802003000100005.
Blood bank audit.
Pinkerton P
J Clin Pathol. 1995; 48(4):283-6.
PMID: 7615842
PMC: 502540.
DOI: 10.1136/jcp.48.4.283.
